Implementation of Standardized Orders for Patients With Severe Sepsis/Septic Shock
- New protocol yields better outcomes. // Healthcare Risk Management;Mar2008, Vol. 30 Issue 3, p34
The article reports on the result of the study conducted by the Barnes-Jewish Hospital in St. Louis, Missouri which focuses on the effectiveness of standardized hospital order set in the management of septic shock.
- Considering CORTICUS: Hydrocortisone in Septic Shock. Akhtar, Saadia R. // Critical Care Alert;Apr2008, Vol. 16 Issue 1, p3
A multicenter, randomized, double-blind, placebo-controlled trial of hydrocortisone replacement in patients with septic shock found no mortality benefit in those patients with inadequate baseline response to corticotropin stimulation.
- Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock. Dhainaut, Jean-Francois; Antonelli, Massimo; Wright, Patrick; Desachy, Arnaud; Reignier, Jean; Lavoue, Sylvain; Charpentier, Julien; Belger, Mark; Cobas-Meyer, Michael; Maier, Cornelia; Mignini, Mariano A.; Janes, Jonathan // Intensive Care Medicine;Jul2009, Vol. 35 Issue 7, p1319
A correction to the article "Extended drotrecogin alfa (activated) treatment in patients with prolonged septic shock" that is published in the current issue is presented.
- Management of septic shock. Edwards, J.D. // BMJ: British Medical Journal (International Edition);6/19/93, Vol. 306 Issue 6893, p1661
Focuses on the advances in the management of septic shock. Resuscitation of patients with sepsis; Eradication of sepsis with logical supportive measures; Consultation with intensive care unit in acutely ill patients; Need for admission and mechanical ventilation.
- Early goal-directed therapy versus 'early', 'goal-directed' therapy. Saleh, Ahmad // Intensive Care Medicine;Sep2015, Vol. 41 Issue 9, p1723
A letter to the editor is presented in response to the article "A Systematic Review and Meta-analysis of Early Goal-directed Therapy for Septic Shock: The ARISE, ProCESS and ProMISe Investigators" by D. C. Angus and colleagues in the 2015 issue.
- Current strategies for managing the patient with sepsis. Kuhl, David A. // American Journal of Health-System Pharmacy;2/15/2002, Vol. 59 Issue 4, pS9
A patient with sepsis is likely to have symptoms characteristic of the systemic inflammatory response syndrome. Initially, ruling out noninfective causes, locating the site of infection, and obtaining cultures before beginning antimicrobial therapy are critical. Aggressive fluid resuscitation...
- Goal-Directed Therapy for Severe Sepsis. Sarkar, Samir; Kupfer, Yizhak; Tessler, Sidney // New England Journal of Medicine;3/28/2002, Vol. 346 Issue 13, p1025
A letter to the editor is presented in response to the article "Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock" in the November 8, 2001 issue.
- Innovative Therapies for Sepsis. Krishnagopalan, S.; dellinger, R.P. // BioDrugs;2001, Vol. 15 Issue 10, p645
Sepsis and septic shock continue to be a major cause of morbidity and mortality. Despite numerous advances in the supportive care of patients with sepsis, the overall mortality has changed little in the past 20 years. Many innovative therapies have been attempted in the field of sepsis,...
- New Approaches in the Management of Septic Shock. Bertolaccini, L.; Barberis, L.; Massaglia, F.; Manno, E. // Current Medicinal Chemistry - Immunology, Endocrine & Metabolic ;Sep2003, Vol. 3 Issue 3, p251
In fact sepsis remains a major cause of death in hospitalized patients. More than 750,000 cases of severe sepsis occur annually in the United States, and the mortality rate is about 30%. As a condition that disproportionately affects the elderly and is related to invasive and immunosuppressive...